Acorda Therapeutics Inc EPS Q/Q
Mi az Acorda Therapeutics Inc EPS Q/Q?
A EPS Q/Q az Acorda Therapeutics Inc - 3.62%
Mi a EPS Q/Q meghatározása?
A negyedévenkénti EPS negyedéves növekedési ráta az elmúlt 4 negyedévben a vállalat EPS-jének növekedése az előző 4 negyedév teljesítményéhez képest.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q/Q a Health Care szektor a NASDAQ-on cégekben a Acorda Therapeutics Inc -hoz képest
Mit csinál Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
eps q/q -hoz hasonló cégek Acorda Therapeutics Inc
- Kellanova Co nak EPS Q/Q 3.51% van
- QIWI plc nak EPS Q/Q 3.51% van
- Microsoft nak EPS Q/Q 3.52% van
- Nio Inc Nio American Depositary nak EPS Q/Q 3.57% van
- PennantPark Floating Rate Capital Ltd nak EPS Q/Q 3.57% van
- National Research Corp nak EPS Q/Q 3.57% van
- Acorda Therapeutics Inc nak EPS Q/Q 3.62% van
- PNM Resources Inc nak EPS Q/Q 3.64% van
- People's Utah Bancorp nak EPS Q/Q 3.64% van
- Wacker Chemie AG nak EPS Q/Q 3.67% van
- Neoleukin Therapeutics nak EPS Q/Q 3.70% van
- CMS nak EPS Q/Q 3.70% van
- Tufin Software Technologies Ltd nak EPS Q/Q 3.70% van